Double-blind, Randomized, Controlled Clinical Trial to Assess Efficacy of MSC in Patients With COVID-19 ARDS

Clinical trial NCT04615429 · COMPLETED

Trial details

NCT number: NCT04615429
Sponsor: Cristina Avendaño Solá
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Acute Respiratory Distress Syndrome COVID-19 Pneumonia

Start date: 2020-09-15
Primary completion: 2022-01-01
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.